Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis (Q37018032)

17 August 2017

0 references

Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis (English)

1 reference

17 August 2017

0 references

1 reference

1 reference

2

Daniel H Solomon

1 reference

17 August 2017

Lydia Gedmintas

1

1 reference

17 August 2017

Seoyoung C Kim

series ordinal

3

1 reference

17 August 2017

language of work or name

1 reference

1 August 2013

1 reference

Journal of Bone and Mineral Research

17 August 2017

1 reference

17 August 2017

28

1 reference

17 August 2017

8

1 reference

17 August 2017

1729-1737

1 reference

Continuing bisphosphonate treatment for osteoporosis--for whom and for how long?

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713078

Bisphosphonates for osteoporosis--where do we go from here?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713078

Incidence and demography of femur fractures with and without atypical features

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713078

Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713078

Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: a register-based national cohort analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713078

Trends in incidence of subtrochanteric fragility fractures and bisphosphonate use among the US elderly, 1996-2007.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713078

Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713078

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713078

Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713078

Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713078

Severely suppressed bone turnover: a potential complication of alendronate therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713078

Quantifying heterogeneity in a meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713078

Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713078

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713078

What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713078

Meta-analysis in clinical trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713078

Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713078

Incidence of atypical nontraumatic diaphyseal fractures of the femur

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713078

Increasing occurrence of atypical femoral fractures associated with bisphosphonate use.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713078

Clinical correlates of atypical femoral fracture.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713078

Hip and subtrochanteric or diaphyseal femoral fractures in alendronate users: a 10-year, nationwide retrospective cohort study in Taiwanese women

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713078

Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713078

Estimating bisphosphonate use and fracture reduction among US women aged 45 years and older, 2001-2008.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713078

Fragility fractures of the hip and femur: incidence and patient characteristics

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713078

Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713078

Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women

4 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FJBMR.1893

Atypical fractures and bisphosphonate therapy: A cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FJBMR.1893

Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23408697

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Bisphosphonate Use and Atypical Fractures of the Femoral Shaft

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23408697

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/JBMR.1893

1 reference

release_bah24b3munggfk7hwlt72jwz6u

17 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bah24b3munggfk7hwlt72jwz6u

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

17 August 2017

1 reference